ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUSROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUSROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS

ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪221.90 B‬USD
‪12.79 B‬USD
‪65.34 B‬USD
‪5.52 B‬
Beta (1Y)
0.03

About ROCHE I


CEO
Thomas Schinecker
Headquarters
Basel
Website
Founded
1896
FIGI
BBG00JRY9DR7
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
R
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
6.58%
Maturity date
Dec 13, 2051
R
USU75000BT2
ROCHE HLDGS 22/25 REGS
Yield to maturity
6.13%
Maturity date
Mar 10, 2025
R
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.82%
Maturity date
Nov 28, 2044
R
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.36%
Maturity date
Mar 8, 2054
R
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
5.28%
Maturity date
Dec 13, 2031
G
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.20%
Maturity date
Jul 15, 2035
R
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.19%
Maturity date
Mar 8, 2034
R
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.13%
Maturity date
Mar 8, 2054
R
USU75000BL9
ROCHE HLDGS 16/27 REGS
Yield to maturity
5.11%
Maturity date
Jan 28, 2027
R
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.09%
Maturity date
Mar 8, 2031
R
USU75000BP0
ROCHE HLDGS 18/28 REGS
Yield to maturity
5.00%
Maturity date
Sep 17, 2028

Explore more bonds